acetazolamide has been researched along with Water-Electrolyte Imbalance in 10 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Water-Electrolyte Imbalance: Disturbances in the body's WATER-ELECTROLYTE BALANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mullens, W | 5 |
| Dauw, J | 3 |
| Martens, P | 5 |
| Meekers, E | 3 |
| Nijst, P | 4 |
| Verbrugge, FH | 4 |
| Chenot, F | 2 |
| Moubayed, S | 2 |
| Dierckx, R | 2 |
| Blouard, P | 2 |
| Derthoo, D | 2 |
| Smolders, W | 2 |
| Ector, B | 1 |
| Hulselmans, M | 1 |
| Lochy, S | 1 |
| Raes, D | 1 |
| Van Craenenbroeck, E | 1 |
| Vandekerckhove, H | 1 |
| Hofkens, PJ | 1 |
| Goossens, K | 1 |
| Pouleur, AC | 1 |
| De Ceuninck, M | 1 |
| Gabriel, L | 1 |
| Timmermans, P | 1 |
| Prihadi, EA | 1 |
| Van Durme, F | 1 |
| Depauw, M | 1 |
| Vervloet, D | 1 |
| Viaene, E | 1 |
| Vachiery, JL | 1 |
| Tartaglia, K | 3 |
| Ter Maaten, JM | 3 |
| Bruckers, L | 3 |
| Droogne, W | 3 |
| Troisfontaines, P | 3 |
| Damman, K | 4 |
| Lassus, J | 4 |
| Mebazaa, A | 4 |
| Filippatos, G | 4 |
| Ruschitzka, F | 4 |
| Dupont, M | 4 |
| Augusto, SN | 1 |
| García-Blas, S | 1 |
| Bonanad, C | 1 |
| Llàcer, P | 1 |
| Ventura, S | 1 |
| Núñez, JM | 1 |
| Sánchez, R | 1 |
| Chamorro, C | 1 |
| Fácila, L | 1 |
| de la Espriella, R | 1 |
| Vaquer, JM | 1 |
| Cordero, A | 1 |
| Roqué, M | 1 |
| Ortiz, V | 1 |
| Racugno, P | 1 |
| Bodí, V | 1 |
| Valero, E | 1 |
| Santas, E | 1 |
| Moreno, MDC | 1 |
| Miñana, G | 1 |
| Carratalá, A | 1 |
| Bondanza, L | 1 |
| Payá, A | 1 |
| Cardells, I | 1 |
| Heredia, R | 1 |
| Pellicer, M | 1 |
| Valls, G | 1 |
| Palau, P | 1 |
| Bosch, MJ | 1 |
| Raso, R | 1 |
| Sánchez, A | 1 |
| Bertomeu-González, V | 1 |
| Bertomeu-Martínez, V | 1 |
| Montagud-Balaguer, V | 1 |
| Albiach-Montañana, C | 1 |
| Pendás-Meneau, J | 1 |
| Marcaida, G | 1 |
| Cervantes-García, S | 1 |
| San Antonio, R | 1 |
| de Mingo, E | 1 |
| Chorro, FJ | 1 |
| Sanchis, J | 1 |
| Núñez, J | 1 |
| Theunissen, E | 1 |
| Fontaine, B | 1 |
| FRIEDBERG, V | 1 |
| Schott, HC | 1 |
| Hinchcliff, KW | 1 |
| Thiel, G | 1 |
| Brunner, F | 1 |
| Wunderlich, P | 1 |
| Huguenin, M | 1 |
| Bienko, B | 1 |
| Torhorst, J | 1 |
| Peters-Haefeli, L | 1 |
| Kirchertz, EJ | 1 |
| Peters, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-center, Randomized, Double-blind, Phase IV Clinical Trial on the Diuretic Effects of Acetazolamide in Patients With Decompensated Heart Failure and Volume OveRload[NCT03505788] | Phase 4 | 519 participants (Actual) | Interventional | 2018-11-11 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for acetazolamide and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
[Periodic paralysis: new pathophysiological aspects].
Topics: Acetazolamide; Combined Modality Therapy; Dietary Carbohydrates; Diuretics; Electromyography; Exerci | 2008 |
Treatments affecting fluid and electrolyte status during exercise.
Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Diuretics; Fluid Therapy; Furosemide; Horse D | 1998 |
4 trials available for acetazolamide and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Topics: Acetazolamide; Aged; Diuretics; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Pep | 2022 |
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Topics: Acetazolamide; Acute Disease; Carbonic Anhydrase Inhibitors; Diuretics; Double-Blind Method; Heart F | 2022 |
Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
Topics: Acetazolamide; Acute Disease; CA-125 Antigen; Cardio-Renal Syndrome; Chlorthalidone; Creatinine; Diu | 2017 |
Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
Topics: Acetazolamide; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up S | 2018 |
4 other studies available for acetazolamide and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
Acute Decompensated Heart Failure, Volume, and Acetazolamide. Reply.
Topics: Acetazolamide; Acid-Base Imbalance; Heart Failure; Humans; Urologic Diseases; Water-Electrolyte Imba | 2022 |
Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
Topics: Acetazolamide; Diuretics; Heart Failure; Humans; Male; Prospective Studies; Sodium; Water-Electrolyt | 2023 |
[Medicinal control of fluid retention in pregnancy toxemias].
Topics: Acetazolamide; Body Fluids; Carbonic Anhydrase Inhibitors; Diuretics; Female; Heart Failure; Humans; | 1959 |
Protection of rat kidneys against HgCl2-induced acute renal failure by induction of high urine flow without renin suppression.
Topics: Acetazolamide; Acute Kidney Injury; Animals; Body Weight; Desoxycorticosterone; Diuresis; Furosemide | 1976 |